• DRAMP ID

    • DRAMP01891
    • Peptide Name

    • Brevinin-1VLc (Frogs, amphibians, animals)
    • Source

    • Rana vaillanti (Central American frog)
    • Family

    • Not found
    • Gene

    • Not found
    • Sequence

    • FLPVIASVAAKVLPKVFCFITKKC
    • Sequence Length

    • 24
    • UniProt Entry

    • No entry found
    • Protein Existence

    • Protein level
    • Biological Activity

    • Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal
    • Target Organism

      • Gram-negative bacterium: E. coli (MIC=50 µM);
      • Gram-positive bacterium: S. aureus (MIC=1.5 µM).
      • Yeast: C. albicans (MIC=3 µM).
    • Hemolytic Activity

      • [Ref.19379837] LC50=7 mM against human erythrocytes
    • Cytotoxicity

      • [Ref.19379837] LC50=4mM against HepG2 hepatoma-derived cells
    • Binding Target

    • Not found
    • Linear/Cyclic

    • Cyclic
    • N-terminal Modification

    • Free
    • C-terminal Modification

    • Cyclization (Cys18 and Cys24)
    • Nonterminal Modifications and Unusual Amino Acids

    • Disulfide bond between Cys18 and Cys24.
    • Stereochemistry

    • L
    • Structure

    • Not found
    • Structure Description

    • Not found
    • Helical Wheel Diagram

    • DRAMP01891 helical wheel diagram
    • PDB ID

    • None
    • Predicted Structure

    • Formula

    • C127H208N28O27S2
    • Absent Amino Acids

    • DEGHMNQRWY
    • Common Amino Acids

    • KV
    • Mass

    • 2623.34
    • PI

    • 9.7
    • Basic Residues

    • 4
    • Acidic Residues

    • 0
    • Hydrophobic Residues

    • 14
    • Net Charge

    • +4
    • Boman Index

    • 24.6
    • Hydrophobicity

    • 1.329
    • Aliphatic Index

    • 125.83
    • Half Life

      • Mammalian:1.1 hour
      • Yeast:3 min
      • E.coli:2 min
    • Extinction Coefficient Cystines

    • 125
    • Absorbance 280nm

    • 5.43
    • Polar Residues

    • 4

DRAMP01891

DRAMP01891 chydropathy plot
    • Function

    • Brevinin-1VLc showes particularly high growth-inhibitory potency (MIC < or =3 microM) against a Gram-positive microorganism Staphylococcus aureus and the opportunistic yeast pathogen Candida albicans and potent cytolytic activity (LC(50)< or =8 microM) against both human erythrocytes and HepG2 hepatoma-derived cells. The peptide ia also active against a Gram-negative microorganism Escherichia coli (MIC< or =50 microM).
  • ·Literature 1
    • Title

    • Purification of peptides with differential cytolytic activities from the skin secretions of the Central American frog, Lithobates vaillanti (Ranidae).
    • Reference

    • Comp Biochem Physiol C Toxicol Pharmacol. 2009 Aug;150(2):150-154.
    • Author

    • Conlon JM, Raza H, Coquet L, Jouenne T, Leprince J, Vaudry H, King JD.